Investigation of the use of positron emission tomography for neuroreceptor imaging in rabbit eyes

Ophthalmic Research

Volumn 36, Issue 5, 2004, Pages 255-263

  Wang, Wei Fang ^a   Ishiwata, Kiichi ^a,d   Kiyosawa, Motohiro ^a   Kawamura, Kazunori ^a   Oda, Keiichi ^a   Matsuno, Kiyoshi ^b   Kobayashi, Tadayuki ^c   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c M's Science Corporation   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Iris ciliary body; Neuroreceptor; Positron emission tomography; Rabbit; Retina

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SIGMA 1 OPIATE RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; CILIARY BODY; CONTROLLED STUDY; IMAGE ANALYSIS; IRIS; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; RETINA;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CILIARY BODY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EYE; IRIS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, DOPAMINE D2; RECEPTORS, SIGMA; RETINA;

EID: 10844260580     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081205     Document Type: Article

References (44)

1. Gjedde A: The relation between brain function and cerebral blood flow and metabolism; in Hunt Batjer H (ed): Cerebrovascular Disease. Philadelphia, Lippincott-Raven, 1997, pp 23-40.
2. 18Fdeoxyfluoroglucose. Am J Ophthalmol 1986;101:310-319.
3. Kiyosawa M, Bosley TM, Kushner M, Jamieson D, Alavi A, Savino PJ, Sergott RC, Reivich M: Positron emission tomography to study the effect of eye closure and optic nerve damage on human cerebral glucose metabolism. Am J Ophthalmol 1989;108:147-152.
4. Kiyosawa M, Ishii K, Inoue C, Kawasaki T, Senda M: Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements. Am J Ophthalmol 1996;122:557-567.
5. Choi MY, Lee DS, Hwang JM, Choi DG, Lee KM, Park KH, Yu YS: Characteristics of glucose metabolism in the visual cortex of amblyopes using positron-emission tomography and statistical parametric mapping. J Pediatr Ophthalmol Strabismus 2002;39:11-19.
6. 18F-fluorodeoxyuridine. Ophthalmic Res 1986;18:292-298.
7. 18F-FDG positron emission tomography in orbital lymphoid tumor. Nippon Ganka Gakkai Zasshi 1985;89:1329-1333.
8. Modorati G, Lucignani G, Landoni C, Freschi M, Trabucchi G, Fazio F, Brancato R: Glucose metabolism and pathological findings in uveal melanoma: Preliminary results. Nucl Med Commun 1996;17:1052-1056.
9. Martin WR, Beckman JH, Calne DB, Adam MJ, Harrop R, Rogers JG, Ruth TJ, Sayre CI, Pate BD: Cerebral glucose metabolism in Parkinson's disease. Can J Neurol Sci 1984;11 (1 suppl):169-173.
10. Chase TN, Foster NL, Fedio P, Brooks R, Mansi L, Di Chiro G: Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Ann Neurol 1984;15(suppl):S170-S174.
11. Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Kufferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brucke T: Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder - Implications for psychopharmacology. World J Biol Psychiatry. 2002;3:133-146.
12. Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L. Implications of brain imaging for the management of schizophrenia. Int Clin Psychopharmacol 1998;13(suppl 3):S15-S20.
13. Himber J, Velly J, Kintz P, de Burlet G, Andermann G, Leclerc G: Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control. Methods Find Exp Clin Pharmacol. 1989;11:315-321.
14. Kahaly G, Diaz M, Just M, Beyer J, Lieb W: Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid 1995;5:107-111.
15. Pichler R, Maschek W, Holzinger C: Therapy with somatostatin analogs in patient with orbitopathy and positive octreoscan. Acta Med Austriaca 2001;28:99-101.
16. 2 dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling. J Neurochem 1986;47:196-204.
17. McGonigle P, Wax MB, Molinoff PB: Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci 1988;29:687-694.
18. 2 dopamine binding sites in the human retina. Neurosci Lett 1990;116:81-86.
19. 2 receptors: Characterization by binding or pharmacological studies and physiological functions. Cell Mol Neurobiol 1990;10:303-325.
20. 2 dopamine receptors in vertebrate retinae with anti-peptide antibodies. J Comp Neurol 1993;331:469-481.
21. Goettl VM, Wemlinger TA, Fong TG, Neff NH, Hadjiconstantinou M: Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside. Brain Res 2000;15:877:1-6.
22. Xi X, Chu R, Zhou X, Lu Y, Liu X: Retinal dopamine transporter in experimental myopia. Chin Med J 2002;115:1027-1030.
23. Senda T, Matsuno K, Mita S: The presence of sigma receptor subtypes in bovine retinal membranes. Exp Eye Res 1997;64:857-860.
24. Senda T, Mita S, Kaneda K, Kikuchi M, Akaike A: Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur J Pharmacol 1998;342:105-111.
25. 1-site agonists lower intraocular pressure. J Pharmacol Exp Ther 1999;289:1362-1369.
26. Shamsul OM, Moore P, El-Sherbeny A, Roon P, Agarwal N, Sarthy VP, Casellas P, Ganapathy V, Smith SB: Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Mol Brain Res 2001;95:86-95.
27. 1-receptors, in bovine retinal blood vessels. Curr Eye Res 1991;10:713-718.
28. Mitchell CK, Redburn DA: Analysis of pre- and postsynaptic factors of the serotonin system in rabbit retina. J Cell Biol 1985;100:64-73.
29. 3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest Ophthalmol Vis Sci 1995;36:2238-2245.
30. 7 receptors in rabbit ocular and brain tissues. Neuroscience1998;87:675-689.
31. 1A agonists: Potential use in glaucoma. Evidence from animal studies. Eye 2000;14:454-463.
32. 7 receptor expression in the mammalian retina. Brain Res 2000;875:152-156.
33. Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB: Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res 1997;65:595-602.
34. 1 receptors in eyes by ex vivo autoradiography and in vivo positron emission tomography. Exp Eye Res 2002;75:723-730.
35. 2 receptors in the mouse brain. J Neural Trans 2001;108:1111-1125.
36. 11C]β-CIT from an N-desmethyl precursor on a semi-preparative reversed ODS column. Appl Radiat Isot 2000;52:225-228.
37. 1A receptor in humans. Synapse 1997;25:147-154.
38. 1 receptors. Nucl Med Biol 2001;27:255-261.
39. Watanabe M, Uchida H, Okada H, Shimizu K, Satoh N, Yoshikawa E, Ohmura T, Yamashita T, Tanaka E: A high resolution PET for animal studies. IEEE Trans Med Imag 1992;11:577-580.
40. 11C]nemonapride. Nucl Med Biol 1999;26:291-296.
41. 1 receptors in living human brain. Neuroimage 2001;16(pt 2):S984.
42. 11C]N- methylspiperone, in rats. Ann Nucl Med 1999;13:161-167.
43. Kuge Y, Minematsu K, Hasegawa Y, Yamaguchi T, Mori H, Matsuura H, Hashimoto N, Miyake Y: Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: An insoluble problem by the Harderian glands. J Cereb Blood Flow Metab 1997;17:116-120.
44. Cherry SR, Shao Y, Silverman RW, Meadors K, Siegel S, Chatziioannou A, Young JW, Jones WF, Moyers JC, Newport D, Boutefnouchet A, Farquhar TH, Andreaco M, Paulus MJ, Binkley DM, Nutt R, Phelps ME: MicroPET: A high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci 1997;44:1161-1166.